BAK vs MEOH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BAK · Braskem$1.09 ▲ 2.83%
MEOH · Methanex$66.33 ▲ 1.33%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BAK -56.4%
- MEOH +81.3%
Head to head
| Metric | BAK | MEOH |
|---|---|---|
| Price | $1.09 | $66.33 |
| Change today | ▲ 2.83% | ▲ 1.33% |
| Market cap | $434.35M | $5.13B |
| Return, 3 months | -51.1% | +20.4% |
| Return, year to date | -63.1% | +68.6% |
| Return, 1 year | -56.0% | +79.9% |
| P/E (TTM) | – | 14.6 |
| P/B | -0.2 | 1.8 |
| P/E percentile vs own 5y | 72nd | 64th |
| Dividend yield | – | 1.12% |
| Revenue growth (YoY, latest qtr) | +21.6% | +49.6% |
| Net profit growth (YoY) | +952.1% | +6,715.9% |
| Gross margin | 8.9% | 32.9% |
| Operating margin | 6.0% | 22.6% |
| Net margin | -7.8% | 7.6% |
| Return on equity | – | 13.4% |
| Analyst target vs. price | +37.6% | +13.3% |
| Analyst buy share | 0% | 83% |
| RSI (14) | 34 | 55 |
| 30-day volatility | 156.7% | 52.6% |
| Max drawdown, 1 year | -78.9% | -33.1% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MEOH is the largest of the group by market value.
- MEOH has returned the most over the past year.
- MEOH is growing revenue fastest.
- MEOH keeps the most profit per dollar of sales.
- MEOH has been the calmest stock over the last 30 days.